據(jù)了解，這種食品酶包含來(lái)自豬胰腺中的胰蛋白酶和胰凝乳蛋白酶，旨在用于水解乳清蛋白，用作嬰兒配方食品和后續(xù)配方食品的成分。

 

　　經(jīng)過(guò)評(píng)估，專(zhuān)家小組認(rèn)為，不能排除嬰兒在食用水解乳制得的產(chǎn)品后對(duì)該食物酶產(chǎn)生過(guò)敏性致敏的風(fēng)險(xiǎn)，但認(rèn)為可能性很低。根據(jù)動(dòng)物可食用部位食物酶的來(lái)源、申請(qǐng)人提供的數(shù)據(jù)以及對(duì)基于胰酶的藥物制劑進(jìn)行臨床研究評(píng)估的支持下，專(zhuān)家小組得出結(jié)論，在預(yù)期的使用條件下，豬胰酶不會(huì)引起安全性問(wèn)題。部分原文報(bào)道如下：

 

　　 The food enzyme is a serine protease complex, containing trypsin (EC 3.4.21.4) and chymotrypsin (EC 3.4.21.1), obtained from porcine pancreas by Neova Technologies Inc. The serine protease complex is intended to be used for hydrolysis of whey proteins employed as ingredients of infant formulae and follow‐on formulae. based on maximum use levels and the maximum permitted protein content in infant formulae, dietary exposure to the food enzyme–total organic solids (TOS) was estimated to be 18 mg TOS/kg body weight (bw) per day for infants. In the toxicological evaluation, clinical studies with pharmaceutical preparations containing pancreatic enzymes were considered. Hypersensitivity to the pharmaceuticals was identified as the major side effect. However, allergic reactions to porcine pancreatic enzymes in hydrolysed foods have not been reported. The Panel considered that a risk of allergic sensitisation to this food enzyme after consumption of products prepared by hydrolysis of milk cannot be excluded in infants, but considers the likelihood to be low. based on the origin of the food enzyme from edible parts of animals, the data provided by the applicant, supported by the evaluation of clinical studies with pharmaceutical preparations based on pancreatic enzymes, the Panel concluded that the porcine pancreatic enzymes do not give rise to safety concern under the intended conditions of use.

 

　　本文由食品伙伴網(wǎng)食品資訊中心編輯，供網(wǎng)友參考，歡迎轉(zhuǎn)載，轉(zhuǎn)載請(qǐng)注明出處！有任何疑問(wèn)，請(qǐng)聯(lián)系news@foodmate.net。